RedHill Biopharma Receives Allowances for U.S. Patent Applicat...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, NC, May 26, 2021 /PRNewswire-AsiaNet/ -- - The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted- Enrollment in opaganib's global Phase 2/3 study in hospitalized patients with severe COVID-19 is almost 100% complete- RHB-107's...
Authors: LATEST ASIANET NEWS RELEASES